New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome

Patients with acute coronary syndrome (ACS) usually receive acetylsalicylic acid plus an adenosine diphosphate (ADP) receptor inhibitor to reduce the long‐term risk of recurrent events. However, patients receiving standard antiplatelet prophylaxis still face a substantial risk of recurrent events. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Shinya, Tomita, Aiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2014
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649494/
https://www.ncbi.nlm.nih.gov/pubmed/24452610
http://dx.doi.org/10.1002/clc.22233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649494/
https://www.ncbi.nlm.nih.gov/pubmed/24452610
http://dx.doi.org/10.1002/clc.22233

Ejemplares similares